Feifei Teng

8PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study.

|Mar 11, 2026
Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responses.

Menglin Bai, Tianwen Yin, Xiaohui Li

|Jan 21, 2025
Computed Tomography-Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non-Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy.

Yuxin Geng, Tianwen Yin, Yikun Li

|Feb 20, 2024
Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.

Xiaonan Shi, Peiliang Wang, Yikun Li

|Dec 08, 2021
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer.

Peiliang Wang, Tianwen Yin, Kaikai Zhao

|Nov 23, 2021
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer.

Peiliang Wang, Tianwen Yin, Kaikai Zhao

Pageof 2

Frequent Collaborators

1 joint publications

Peiliang Wang

1 joint publications

Jinming Yu

1 joint publications

Menglin Bai

1 joint publications

Xiao Sun